Key result
Oral anticoagulant use is linked to ~38% lower all-cause mortality in elderly AF patients.
Why the study?
The causes of death and related factors in elderly Japanese patients with atrial fibrillation were not well elucidated.
Does OAC use and the presence of specific clinical factors affect all-cause, cardiovascular, and non-cardiovascular mortality in elderly patients with atrial fibrillation?
Cohort (n=389)
Yes
Does OAC use and the presence of specific clinical factors affect all-cause, cardiovascular, and non-cardiovascular mortality in elderly patients with atrial fibrillation?
In elderly patients with atrial fibrillation, oral anticoagulant use remains protective against mortality, despite non-cardiovascular conditions constituting the predominant causes of death.
Supports OAC consideration in elderly AF despite predominant non-CV mortality; extends observational data but leaves causality open.
Background Oral anticoagulant (OAC) therapy reduces the risk of stroke in patients with atrial fibrillation (AF). This study elucidated the causes of death and related factors in elderly Japanese AF patients. Methods and Results Over a median (interquartile range [IQR]) follow-up period of 46 (20–76) months, there were 171 all-cause deaths (28% cardiovascular, 46% non-cardiovascular, and 26% unknown causes) among 389 AF patients (median [IQR] age 80 [74–85] years; CHAD2DS2-VASc score 5 [4–6]). Cox regression analysis indicated that diabetes was associated with an increase in all-cause death (hazard ratio [HR] 1.48; 95% confidence interval [CI] 1.02–2.13), whereas hypercholesterolemia (HR 0.53; 95% CI 0.35–0.79), pre-existing heart failure (HR 0.67; 95% CI 0.48–0.95), and OAC use (HR 0.62; 95% CI 0.44–0.88) were associated with reductions in all-cause death. Pre-existing heart failure was associated with both cardiovascular (HR 3.03; 95% CI 1.33–8.20) and non-cardiovascular (HR 0.44; 95% CI 0.30–0.65) deaths, in opposite directions. OAC use was associated with a reduction in cardiovascular death (HR 0.34, 95% CI 0.17–0.69). The predominance of non-cardiovascular death and death-related factors were equivalent regardless of when observations started (before 2009 or in 2009 and later). Conclusions The predominant cause of death in elderly Japanese AF patients was non-cardiovascular. Distinct clinical factors were associated with cardiovascular and non-cardiovascular death.
No takes yet. Share an insight, caveat, or question.
Oba et al. (2020) conducted a cohort in Atrial Fibrillation (n=389). Oral anticoagulant (OAC) use and specific clinical factors vs. Non-use of OACs and absence of specific comorbidities was evaluated on All-cause death (HR 0.62, 95% CI 0.44-0.88, p=0.0069). Oral anticoagulant use was associated with a 38% reduction in all-cause death (HR 0.62) in elderly Japanese patients with atrial fibrillation, though non-cardiovascular causes predominated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: